These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30407350)

  • 21. An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma.
    Zarrabi K; Wu S
    Expert Opin Biol Ther; 2018 Jun; 18(6):695-705. PubMed ID: 29782188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine.
    Takayoshi K; Sagara K; Uchino K; Kusaba H; Sakamoto N; Iguchi A; Baba E
    BMC Cancer; 2015 May; 15():426. PubMed ID: 26001650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major response and clinical benefit following third-line treatment for Bellini duct carcinoma.
    Fakhrai N; Haitel A; Balassy C; Zielinski CC; Schmidinger M
    Wien Klin Wochenschr; 2005 Jan; 117(1-2):63-5. PubMed ID: 15986594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Okumi M; Ishida H; Tanabe K
    In Vivo; 2020; 34(3):1541-1546. PubMed ID: 32354960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
    Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
    Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.
    Peyromaure M; Thiounn N; Scotté F; Vieillefond A; Debré B; Oudard S
    J Urol; 2003 Oct; 170(4 Pt 1):1138-40. PubMed ID: 14501710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Subcutaneous Metastasis from Renal Pelvic Carcinoma Growing Rapidly after radical Nephrectomy : A Case Report].
    Koh Y; Yumiba S; Okada T; Satoh M; Nin M; Tsujihata M; Miwa H
    Hinyokika Kiyo; 2016 Mar; 62(3):135-9. PubMed ID: 27133887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Yip SM; Wells C; Moreira R; Wong A; Srinivas S; Beuselinck B; Porta C; Sim HW; Ernst DS; Rini BI; Yuasa T; Basappa NS; Kanesvaran R; Wood LA; Canil C; Kapoor A; Fu SYF; Choueiri TK; Heng DYC
    Cancer; 2018 Sep; 124(18):3677-3683. PubMed ID: 30307610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.
    Ornstein MC; Wood LS; Hobbs BP; Allman KD; Martin A; Bevan M; Gilligan TD; Garcia JA; Rini BI
    J Immunother Cancer; 2019 May; 7(1):127. PubMed ID: 31097024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma.
    Kobari Y; Yoshida K; Iizuka J; Kondo T; Ishida H; Tanabe K; Takagi T
    In Vivo; 2021; 35(6):3585-3589. PubMed ID: 34697199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A CASE OF UNRESECTABLE METASTATIC RENAL CARCINOMA SUCCESSFULLY TREATED BY COMBINED MODALITY THERAPY WITH NIVOLUMAB AND SURGERY].
    Ohmori N; Oki T; Tahara H
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):105-108. PubMed ID: 35444078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A CASE OF RENAL CELL CARCINOMA THAT ONCE NIVOLUMAB HAD BEEN EFFECTIVE IN METASTATIC LESION AND MADE PRIMARY TUMOR RESECTABLE].
    Tsukahara S; Nagatomi Y; Otsubo S; Hasegawa S
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):32-35. PubMed ID: 31956216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
    Harada M; Naoi H; Yasuda K; Ito Y; Kagoo N; Kubota T; Ichijo K; Mochizuki E; Uehara M; Matsuura S; Tsukui M; Koshimizu N
    BMC Pulm Med; 2021 Jan; 21(1):6. PubMed ID: 33407304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
    Koie T; Ohyama C; Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y
    BMC Res Notes; 2013 Nov; 6():484. PubMed ID: 24267160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nivolumab-ipilimumab in renal cell carcinoma metastatic to the bones: A case report.
    Di Napoli M; Pisano C; Setola SV; Perdonà S; Feroce F; Pignata S
    Acta Biomed; 2022 Jun; 93(S1):e2022132. PubMed ID: 35765962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.
    Escudier B; Motzer RJ; Sharma P; Wagstaff J; Plimack ER; Hammers HJ; Donskov F; Gurney H; Sosman JA; Zalewski PG; Harmenberg U; McDermott DF; Choueiri TK; Richardet M; Tomita Y; Ravaud A; Doan J; Zhao H; Hardy H; George S
    Eur Urol; 2017 Sep; 72(3):368-376. PubMed ID: 28410865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.
    Yoshida K; Takagi T; Kondo T; Kobayashi H; Iizuka J; Fukuda H; Ishihara H; Okumi M; Ishida H; Tanabe K
    Jpn J Clin Oncol; 2019 Jun; 49(6):576-580. PubMed ID: 30924496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
    Remolina-Bonilla YA; Jimenez-Franco B; Lam ET; Bourlon MT
    Oncology (Williston Park); 2020 May; 34(5):171-174. PubMed ID: 32644176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
    Rizvi NA; Hellmann MD; Brahmer JR; Juergens RA; Borghaei H; Gettinger S; Chow LQ; Gerber DE; Laurie SA; Goldman JW; Shepherd FA; Chen AC; Shen Y; Nathan FE; Harbison CT; Antonia S
    J Clin Oncol; 2016 Sep; 34(25):2969-79. PubMed ID: 27354481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.
    Sheng X; Cao D; Yuan J; Zhou F; Wei Q; Xie X; Cui C; Chi Z; Si L; Li S; Mao L; Lian B; Tang B; Yan X; Wang X; Kong Y; Dai J; Bai X; Zhou L; Guo J
    Eur J Cancer; 2018 Sep; 100():1-7. PubMed ID: 29933095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.